Back to Search
ANDREW MCCOLLUM, MD
MD
Medical Oncology Physician
NPI: 1407898505IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
K1252(TX)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
K1252(TX)
Education
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Class of 1995
Research & Publications (20)
Stage III colon cancer at Baylor University Medical Center at Dallas and the Baylor Sammons Cancer Center: experience from 2000 to 2004.
PMID 17106492·Proc (Bayl Univ Med Cent)·2006
8-other
The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer.
PMID 16462501·Am J Clin Oncol·2006
3-trial
Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.
PMID 15596916·Am J Clin Oncol·2004
8-other
Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria.
PMID 19258269·Antimicrob Agents Chemother·2009
7-preclinical
Cisplatin abrogates the geldanamycin-induced heat shock response.
PMID 18852129·Mol Cancer Ther·2008
8-other
P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response.
PMID 18794130·Cancer Res·2008
8-other
Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru.
PMID 18025120·Antimicrob Agents Chemother·2008
7-preclinical
Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation.
PMID 18321547·Trans R Soc Trop Med Hyg·2008
3-trial
Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from central Africa.
PMID 18765692·Antimicrob Agents Chemother·2008
7-preclinical
Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America.
PMID 17283199·Antimicrob Agents Chemother·2007
7-preclinical
Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation.
PMID 17317822·Clin Cancer Res·2007
8-other
Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles.
PMID 16779725·J Infect Dis·2006
7-preclinical
Pyrosequencing, a high-throughput method for detecting single nucleotide polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
PMID 16957045·J Clin Microbiol·2006
7-preclinical
Inhibition of calpain-mediated cell death by a novel peptide inhibitor.
PMID 16956607·Exp Neurol·2006
4-observational
Up-regulation of heat shock protein 27 induces resistance to 17-allylamino-demethoxygeldanamycin through a glutathione-mediated mechanism.
PMID 17108135·Cancer Res·2006
8-other
A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer.
PMID 17062684·Clin Cancer Res·2006
3-trial
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
PMID 14966087·J Clin Oncol·2004
8-other
Oxidative stress inhibits ionomycin-mediated cell death in cortical neurons.
PMID 15048934·J Neurosci Res·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3410 WORTH ST STE 400
DALLAS, TX 75246 - Phone
- (214) 370-1000
Quick Facts
- NPI
- 1407898505
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile